Erwin Robin

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes

Vilasini Shetty, Suneel Mundle, Sairah Alvi et al. · Leukemia Research · 1996 · 179 citations

Life Sciences, Cell Biology, Immunology +9

A Comparative Study of Nitroglycerin and Propranolol

Erwin Robin, Charles Cowan, Pritpal S. Puri et al. · Circulation · 1967 · 102 citations · Full text

Life Sciences, Pharmacology, Physiology +17

Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone

Azra Raza, Huma Qawi, Laurie Lisak et al. · Blood · 2000 · 73 citations

Medicine, Pharmacology, Pharmacotherapy +12